Blog
Blog
Why Enterprise AI Feels Like a Disappointment for Life Sciences Teams
You have used tools like ChatGPT. They are fast, helpful, almost fun. Then your company deploys its own AI platform and something feels off. It hedges. It refuses. It does not understand your business, markets, or data. You are not imagining the gap.
Filter posts by:
Blog
From Insights to Impact: How AI Is Transforming Pharmaceutical Competitive Intelligence
Pharmaceutical competitive intelligence (CI) has quietly become one of pharma’s most strained functions. The TGaS Competitive Intelligence Landscape Survey (October 2025) shows competitive complexity accelerating at a pace that traditional CI models cannot absorb.
Blog
Why Enterprise AI Feels Like a Disappointment for Life Sciences Teams
You have used tools like ChatGPT. They are fast, helpful, almost fun. Then your company deploys its own AI platform and something feels off. It hedges. It refuses. It does not understand your business, markets, or data. You are not imagining...
Blog
From Patent Cliff to AI Gaps: Six Commercialization Challenges Shaping Pharma in 2026
Trinity recently convened its leadership team to examine the scale of the industry’s current commercialization challenges and stress test the solutions we are bringing to clients. Our senior leadership articulated the six most material issues facing biopharma today and created space...
Trinity: Deep Dive
From Static Insights to Always On Intelligence
There is a growing paradox in life sciences commercialization: more data and more research than ever, yet many critical decisions still rely on static decks, siloed databases, and one time studies that go stale almost immediately. Commercial, medical, and market access...
Trinity: Deep Dive
The AI Context Layer: The Missing Link in AI-Ready Data
Most commercial life sciences organizations have invested heavily in data. They have lakehouses, harmonized data feeds, and dashboard environments like Power BI, Tableau, and Snowflake that teams rely on daily. These tools already carry semantic models: metric definitions, schema relationships, and...
Trinity: Deep Dive
De-Risk Market Access: Simulate Payer Decisions Before You Go to Market
Market access teams routinely make high-stakes decisions with incomplete information and compressed timelines. Primary market research remains the gold standard, but in-depth interviews with payers are expensive, logistically complex, and difficult to repeat iteratively as strategy and data evolves. The result...
